Point72 Hong Kong LTD Abbott Laboratories Call Options Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $77,408 - $89,624	800 Added 2.99%	27,600 $2.67 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $1.27 Million - $1.53 Million	12,400 Added 86.11%	26,800 $2.91 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $2.3 Million - $2.81 Million	-20,200 Reduced 58.38%	14,400 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.81 Million - $2.22 Million	15,700 Added 83.07%	34,600 $4.87 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $198,322 - $219,402	-1,700 Reduced 8.25%	18,900 $2.23 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.14 Million - $1.34 Million	10,800 Added 110.2%	20,600 $2.39 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $1.07 Million - $1.26 Million	9,800 New	9,800 $1.17 Million

3,184

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.